Statistics

Total Visits

Views
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents(legacy) 130
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents(legacy) 78

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents 2 5 2 3 1 5 1

File Downloads

Views

Top Country Views

Views
United States 67
Australia 18
France 9
China 8
Netherlands 8
Vietnam 5
Hong Kong SAR China 2
Ireland 2
Brazil 1
Canada 1

Top City Views

Views
Ashburn 26
Kaleen 15
Fairfield 12
Rotterdam 8
Hanoi 5
Beijing 3
Cambridge 2
Central 2
Chicago 2
Dearborn 2